| Advantages | They are invaluable for disease modeling, drug testing, and evaluating gastric responses to pathogens and treatments in porcine models. Compared to traditional 2D cultures, these organoids offer a more accurate representation of the pig stomach, making them critical tools for zoonotic disease research, veterinary medicine, and preclinical drug testing. |
| Species | Porcine |
| Product Type | Tissue-derived Organoid |
| Growth Properties | Embedded 3D Culture |
| Growth Conditions | Cultured at 37°C under 95% air and 5% CO2. |
| Quality Control | Negative for mycoplasma, bacteria, yeast, and fungi. |
| Tissue | Gastric |
| Disease | Normal |
| Format | Frozen |
| Organoid Characterization | They closely resemble the gastric epithelium, including gastric pits, parietal cells, and chief cells, while preserving native gastric mucosal architecture. These organoids provide a physiologically relevant system for studying gastric development, gastritis, gastric cancer, and other gastrointestinal diseases specific to pigs. |
| Applications | Tissue-derived organoids are extensively utilized in drug screening, disease modeling, mechanistic research, personalized medicine, and regenerative medicine. By recapitulating authentic disease states, they provide a robust platform for evaluating patient-specific drug responses and supporting individualized treatment design. Moreover, these organoids enable the development of innovative therapeutic strategies, especially in cancer research and organ regeneration, delivering precise experimental systems that significantly advance precision medicine. |
| Storage | Liquid Nitrogen |
| Shipping Information | Dry Ice |
For preclinical research and development use only; not intended for therapeutic or other applications.
Alfa Cytology is a preclinical research service provider specializing in tumor organoid development. We provide one-stop services that include tailored 3D cancer models, organoid-based research services, and related products to accelerate the discovery and development of cancer therapeutics.
Copyright © 2026 Alfa Cytology. All rights reserved.